Diagnostics for COVID-19

In response to the COVID-19 pandemic, a team of volunteers at the CReM led by George Murphy and in collaboration with the Department of Pathology and Laboratory Medicine at BMC led by Chris Andry we have developed an assay for the diagnostics of the infection caused by SARS-CoV-2.

EUA or the CReM
in house protocol.

For inquiries about the protocol please contact George Murphy at gjmurphy@bu.edu

Diagnostics for COVID-19

COVID-19 is a significant public health crisis. However, we believe the collaborative and committed work from the medical field will help us through this challenge together. We have prepared and would like to share some resources with our colleagues both in the clinical and in the basic science fields.

If you are a clinician:

Please click below to find resources such as guidelines for managing critically ill COVID-19 patients, tutorials for proper PPE use, and online critical care training for non-ICU doctors.

If you are a basic science researcher:

Please click below to learn about our iPSC based airway and alveolar models that can potentially be used to study COVID-19. We have posted our unpublished COVID-19 relevant gene expression profiles of our cells to facilitate your brainstorming, and we are eager to collaborate with you!

Diagnostics for COVID-19

The Center for Regenerative Medicine (CReM) iPSC Core was created to expedite the use of iPSC technology by providing essential services and support to on-campus investigators and the broader scientific community. To achieve this goal the CReM iPSC Core will:

Make a monetary donation
to support our cell sharing mission.

If you want to support our mission, please click on the link below.